Report Overview

Indian Chronic Inflammatory Demyelinating Polyneuritis Market size stood at USD XX Billion in 2019 and is projected to reach USD XX Billion by 2028, exhibiting a CAGR of XX% during the forecast period.

Chronic inflammatory demyelinating polyneuropathy is one of the neurological disorder in which the body immune system may attacks myelin, its an important part of the nervous system. This disease can cause pain, impaired ability, loss of sensation, chronic fatigue and other problems, various treatments can be used to treat this disease like intravenous immunoglobulin, plasmapheresis, physiotherapy and others.Air pollution has the potential to cause genetic changes that result in autoimmune diseases, which are a case of the bodys immune system mistaking one of its own cells for an alien object and responding to it likewise, i.e. by attacking it. Nicotine also has the potential to cause autoimmune diseases and has been linked with an increase in the risk of autoimmune diseases, especially if consumed daily or heavily.



Market Drivers

The rise in the incidence of harmful habits such as excessive smoking, excessive sedentariness, and excessive consumption of pollutants present in the air in urban centers has resulted in a growing incidence of autoimmune diseases. Air pollution has the potential to cause genetic changes that result in autoimmune diseases, which are a case of the bodys immune system mistaking one of its own cells for an alien object and responding to it likewise, i.e. by attacking it. The growing prevalence of such habits is likely to remain a key driver for the Indian chronic inflammatory demyelinating polyneuropathy market over the forecast period.